Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06512155Phase 1Completed
Phase 1, randomised, open-label trial of pregabalin in sleep disorder (3 arms). Primary endpoint: Athens Insomnia Scale. Started Jul 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06512155.